NASDAQ:MRM Medirom Healthcare Technologies (MRM) Stock Price, News & Analysis $0.35 +0.01 (+3.11%) Closing price 04:00 PM EasternExtended Trading$0.36 +0.01 (+4.08%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsNews and TrendsSEC Filings About Medirom Healthcare Technologies Stock (NASDAQ:MRM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MRM alerts:Sign Up Key Stats Today's Range$0.33▼$0.3550-Day Range$0.33▼$1.0852-Week Range$0.25▼$2.85Volume58,631 shsAverage Volume397,475 shsMarket Capitalization$9.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Medirom Healthcare Technologies Inc. is a Japan-based healthcare and wellness company that provides relaxation, body-care and preventive-health services. Its core business operates under the Re.Ra.Ku brand, a network of studios offering services such as relaxation treatments, stretching and other wellness programs intended to support customers’ physical well-being. The company also develops digital preventive-healthcare products and services. These initiatives include wearable technology designed to collect health-related data and support ongoing wellness management, including the MOTHER Bracelet, a device marketed as a low-maintenance activity and health-monitoring wearable. Medirom serves customers primarily in Japan through its physical locations and technology-based healthcare offerings. The company was established in 2000 and began trading on the Nasdaq under the symbol MRM in 2020. Its operations combine in-person wellness services with digital tools intended to encourage preventive healthcare and healthier lifestyles.AI Generated. May Contain Errors. Read More Medirom Healthcare Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks11th Percentile Overall ScoreMRM MarketRank™: 0.565637832825 of 5 starsMedirom Healthcare Technologies scored higher than 11% of companies evaluated by MarketBeat, and ranked 455th out of 483 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingMedirom Healthcare Technologies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageMedirom Healthcare Technologies has only been the subject of 1 research reports in the past 90 days.Read more about Medirom Healthcare Technologies' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioMedirom Healthcare Technologies has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.02% of the float of Medirom Healthcare Technologies has been sold short.Short Interest Ratio / Days to CoverMedirom Healthcare Technologies has a short interest ratio ("days to cover") of 0.14, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Medirom Healthcare Technologies has recently decreased by 78.62%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMedirom Healthcare Technologies does not currently pay a dividend.Dividend GrowthMedirom Healthcare Technologies does not have a long track record of dividend growth. News and Social MediaN/ANews SentimentN/A Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Medirom Healthcare Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders40.24% of the stock of Medirom Healthcare Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsMedirom Healthcare Technologies has minimal institutional ownership at this time.Read more about Medirom Healthcare Technologies' insider trading history. Receive MRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medirom Healthcare Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MRM Stock News HeadlinesMedirom Healthcare Technologies Inc. (NASDAQ:MRM) Sees Large Decrease in Short InterestOctober 11, 2026 | americanbankingnews.comMEDIROM Healthcare Technologies, Inc. Sponsored ADRAugust 10, 2026 | cnn.comTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and payment networks that bypass the dollar entirely. Since the Federal Reserve opened in 1913, the dollar has lost most of its purchasing power. Porter Stansberry argues a new monetary order is forming around AI infrastructure, chips and energy, pointing to stocks like Vertiv, GE Vernova and Arista Networks that have surged hundreds of percent in recent years.October 22 at 1:00 AM | Porter & Company (Ad)MEDIROM Healthcare Technologies (MRM) stock forecast and price targetJuly 23, 2026 | finance.yahoo.comMEDIROM MOTHER Labs Expands Deployment of "REMONY®" Remote Health Monitoring System in JGSDF 8th DivisionJune 25, 2026 | globenewswire.comMEDIROM Group Reports Q1 2026 ResultsMay 28, 2026 | globenewswire.comMEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 ...February 27, 2026 | markets.businessinsider.comMEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide LocationsFebruary 27, 2026 | globenewswire.comSee More Headlines MRM Stock Analysis - Frequently Asked Questions How have MRM shares performed this year? Medirom Healthcare Technologies' stock was trading at $1.94 at the beginning of the year. Since then, MRM stock has decreased by 82.1% and is now trading at $0.3478. When did Medirom Healthcare Technologies IPO? Medirom Healthcare Technologies (MRM) raised $12 million in an initial public offering (IPO) on Tuesday, December 29th 2020. The company issued 800,000 shares at $15.00 per share. Maxim Group LLC served as the underwriter for the IPO. How do I buy shares of Medirom Healthcare Technologies? Shares of MRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (5m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 MRM's financial health is in the Red zone, according to TradeSmith. MRM has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Discretionary Industry Diversified Consumer Services Sub-IndustryN/A Current SymbolNASDAQ:MRM Previous SymbolNYSE:MRM CIK1819704 Webmedirom.co.jp Phone81-3-6721-7364FaxN/AEmployees1,051Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$54.89 million Price / Sales0.18 Cash Flow$0.10 per share Price / Cash Flow3.46 Book Value$0.23 per share Price / Book1.51Miscellaneous Outstanding Shares28,390,000Free Float16,964,000Market Cap$9.87 million OptionableN/A Beta1.26 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:MRM) was last updated on 10/22/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredPaid at 10:22 AMMost same-day options traders pay first and hope the market cooperates before the bell. There's another approa...Profits Run | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medirom Healthcare Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medirom Healthcare Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
